Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study-Reference-Cited by-同舟云学术

Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study

Published:2015-03-11 Issue:5 Volume:17 Page:708-717
ISSN:1523-5866
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Nabors L. Burt,Fink Karen L.,Mikkelsen Tom,Grujicic Danica,Tarnawski Rafal,Nam Do Hyun,Mazurkiewicz Maria,Salacz Michael,Ashby Lynn,Zagonel Vittorina,Depenni Roberta,Perry James R.,Hicking Christine,Picard Martin,Hegi Monika E.,Lhermitte Benoit,Reardon David A.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/17/5/708/16860698/nou356.pdf

Reference19 articles.

1. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006–2010;Ostrom;Neuro Oncol,2013

2. Drug resistance in glioblastoma: a mini review;Haar;Neurochem Res,2012

3. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

4. Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide;Hegi;Clin Cancer Res,2004

Cited by 187 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Radionuclide Therapy in Glioblastoma;ACS Applied Materials & Interfaces;2024-07-23

2. Current status of precision oncology in adult glioblastoma;Molecular Oncology;2024-06-20

3. L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trial;Nature Communications;2024-05-28

4. TGF-β signaling in health, disease and therapeutics;Signal Transduction and Targeted Therapy;2024-03-22

5. Deep-learning-based reconstruction of undersampled MRI to reduce scan times: a multicentre, retrospective, cohort study;The Lancet Oncology;2024-03